Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
256.69
274.01
211.48
289.42
235.99
214.52
229.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
256.69
274.01
211.48
289.42
235.99
214.52
229.60
Raw Material Cost
65.64
85.43
59.35
95.47
75.45
89.14
75.01
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.33
0.34
0.35
0.32
0.32
0.33
0.29
Selling and Distribution Expenses
109.78
100.86
97.71
109.30
103.85
109.00
102.97
Other Expenses
-0.03
-0.03
-0.04
-0.03
-0.03
-0.03
-0.03
Total Expenditure (Excl Depreciation)
175.43
186.30
157.07
204.76
179.30
198.14
177.98
Operating Profit (PBDIT) excl Other Income
81.30000000000001
87.69999999999999
54.400000000000006
84.7
56.7
16.4
51.6
Other Income
5.15
4.91
-1.84
-3.67
8.59
-8.42
4.88
Operating Profit (PBDIT)
91.12
97.21
56.78
85.88
69.75
11.75
58.78
Interest
0.33
0.34
0.35
0.32
0.32
0.33
0.29
Exceptional Items
0.17
0.00
5.34
0.00
0.03
0.00
0.36
Gross Profit (PBDT)
191.04
188.58
152.12
193.95
160.54
125.39
154.59
Depreciation
4.71
4.59
4.21
4.90
4.47
3.79
2.27
Profit Before Tax
86.25
92.28
57.56
80.66
64.99
7.64
56.57
Tax
-20.32
11.61
-3.39
-35.02
3.14
-12.52
5.22
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
106.58
80.68
60.95
115.69
61.85
20.16
51.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
106.58
80.68
60.95
115.69
61.85
20.16
51.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
106.58
80.68
60.95
115.69
61.85
20.16
51.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,762.56
1,655.98
1,575.31
1,514.36
1,398.67
1,336.82
1,316.66
Earnings per share (EPS)
11.44
8.66
6.54
12.42
6.64
2.16
5.51
Diluted Earnings per share
11.44
8.66
6.54
12.42
6.64
2.16
5.51
Operating Profit Margin (Excl OI)
31.66%
32.01%
25.73%
29.25%
24.02%
7.64%
22.48%
Gross Profit Margin
35.44%
35.35%
29.21%
29.56%
29.43%
5.33%
25.63%
PAT Margin
41.52%
29.44%
28.82%
39.97%
26.21%
9.4%
22.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is -6.31% vs 29.55% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 32.09% vs 32.51% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is -6.83% vs 57.51% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -25.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
Compare Quarterly Results Of Immuno-Biological Laboratories Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(JPY)
Change(%)
Net Sales
256.69
7,842.29
-7,585.60
-96.73%
Other Operating Income
0.00
0.00
0.00
Total Operating income
256.69
7,842.29
-7,585.60
-96.73%
Raw Material Cost
65.64
6,465.22
-6,399.58
-98.98%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.33
11.23
-10.90
-97.06%
Selling and Distribution Expenses
109.78
1,240.96
-1,131.18
-91.15%
Other Expenses
-0.03
-1.12
1.09
97.32%
Total Expenditure (Excl Depreciation)
175.43
7,706.18
-7,530.75
-97.72%
Operating Profit (PBDIT) excl Other Income
81.26
136.10
-54.84
-40.29%
Other Income
5.15
83.81
-78.66
-93.86%
Operating Profit (PBDIT)
91.12
297.94
-206.82
-69.42%
Interest
0.33
11.23
-10.90
-97.06%
Exceptional Items
0.17
-24.39
24.56
100.70%
Gross Profit (PBDT)
191.04
1,377.07
-1,186.03
-86.13%
Depreciation
4.71
78.02
-73.31
-93.96%
Profit Before Tax
86.25
184.30
-98.05
-53.20%
Tax
-20.32
42.98
-63.30
-147.28%
Provisions and contingencies
0
0
0.00
Profit After Tax
106.58
137.02
-30.44
-22.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
106.58
137.02
-30.44
-22.22%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
4.30
-4.30
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
106.58
141.32
-34.74
-24.58%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,762.56
7,654.07
-5,891.51
-76.97%
Earnings per share (EPS)
11.44
23.64
-12.20
-51.61%
Diluted Earnings per share
11.44
23.64
-12.20
-51.61%
Operating Profit Margin (Excl OI)
31.66%
1.74%
0.00
29.92%
Gross Profit Margin
35.44%
3.34%
0.00
32.10%
PAT Margin
41.52%
1.75%
0.00
39.77%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 25.67 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -6.31% vs 29.55% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 8.77% vs 29.03% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 10.66 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 32.09% vs 32.51% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 72.49% vs 1,080.95% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.60 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -6.83% vs 57.51% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 40.52% vs 1,669.23% in Dec 2024
Quarterly - Interest
Interest 0.03 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -25.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.66%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
